Corticosteroids + Ustekinumab Auub Interaction
Moderateinteraction on record
Description
Used concomitantly in approximately 40% of Crohn's disease and 50% of ulcerative colitis subjects; did not appear to influence overall safety or efficacy of ustekinumab.
Source: NLP:ustekinumab-auub